Bio-IT World April 19, 2024
Commentary Contributed by Luke Piggott, Debiopharm
In modern medicine, biomarkers stand as pivotal indicators of biological processes or responses to therapeutic interventions, signaling a new era in clinical trial design and patient care. The driving idea behind the use of these tools is that by integrating the right biomarker information, scientists can properly select patients who are most likely to benefit from a particular therapy. This strategic approach not only enhances treatment efficacy but also minimizes the likelihood of patients experiencing unnecessary side effects from treatments that may not benefit them. Because of this, clinical trials are becoming more frequently driven by biomarkers to optimize and personalize disease treatment.
Beyond the immediate benefits to patient...
Today's Sponsors
Today's Sponsor